To test this hypothesis, we have utilized gene expression data and clinical data from the Cancer Genome Atlas Project (http://cancergenome.nih.gov/) to test the association between an IFN/STAT1 pathway signature derived from the IRDS with survival outcome of GBM patients. Here, IFNA1 is linked to glioblastoma.